# J. Simon R. Gibbs

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/j-simon-r-gibbs/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,623 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 87 |
| i10-index | 166 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5026902884 |
| ORCID iD | https://orcid.org/0000-0001-6147-9252 |
| Works | 269 |

## Researcher papers

- [2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era](https://scholariq.org/papers/connective-tissue-disease-associated-pulmonary-arterial-hypertension-in-the/)
- [Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry](https://scholariq.org/papers/elderly-patients-diagnosed-with-idiopathic-pulmonary-arterial-hypertension/)
- [Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension](https://scholariq.org/papers/improved-outcomes-in-medically-and-surgically-treated-chronic-thromboembolic/)
- [ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy](https://scholariq.org/papers/esc-guidelines-on-the-management-of-cardiovascular-diseases-during-pregnancy/)
- [Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension](https://scholariq.org/papers/prognostic-and-aetiological-factors-in-chronic-thromboembolic-pulmonary/)
- [Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.